David L Lowrance's Net Worth
$2.21 Million
Who is David L Lowrance?
David L Lowrance has an estimated net worth of $2.21 Million. This is based on reported shares across multiple companies, which include ACUCELA INC., Savara Inc, and CUMBERLAND PHARMACEUTICALS INC.
SEC CIK
David L Lowrance's CIK is 0001408498
Past Insider Trading and Trends
2019 was David L Lowrance's most active year for acquiring shares with 6 total transactions. David L Lowrance's most active month to acquire stocks was the month of November. 2019 was David L Lowrance's most active year for disposing of shares, totalling 10 transactions. David L Lowrance's most active month to dispose stocks was the month of March. 2014 saw David L Lowrance paying a total of $183,060.00 for 40,500 shares, this is the most they've acquired in one year. In 2014 David L Lowrance cashed out on 81,000 shares for a total of $468,585.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACUCELA INC. No price found
CFO, Secretary, Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$5.79 | -$102,465.00 |
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Savara Inc (SVRA) Snapshot price: $4.42
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.84% | -10.00K |
$4.71 | -$47,131.00 | 342.36K |
Dec 28
| |||
Form 4
| +45.13% | 109.56K |
$4.45 | -$135,449.10 | 352.36K |
Dec 14 - Dec 15
| |||
Form 4
| +70.03% | 100K |
—
|
—
| 242.79K |
Dec 13
| |||
Form 4
| +2.88% | 4K |
$1.14 | $4,568.80 | 142.79K |
Dec 17
| |||
Form 4
| +906.26% | 125K |
—
|
—
| 138.79K |
Dec 14
| |||
Form 4
|
∞
| 13.79K |
$1.45 | $19,999.85 | 13.79K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
$6.15 | -$69,601.46 |
0
|
Scheduled
|
May 1 - May 2
| ||
Form 4
|
—
|
0
|
$5.27 | -$56,349.79 |
0
|
Scheduled
|
Apr 4 - Apr 8
| ||
Form 4
| -100.00% | -18.48K |
$9.22 | -$170,476.15 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
| -22.21% | -5.28K |
$12.08 | -$63,727.31 | 18.48K |
Scheduled
|
Jun 8 - Jun 12
| ||
Form 4
| +1,031.19% | 21.66K |
$7.54 | -$90,748.84 | 23.75K |
Scheduled
|
Jan 2 - Feb 15
| ||
Form 4
|
∞
| 2.1K |
$4.75 | $9,975.00 | 2.1K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CUMBERLAND PHARMACEUTICALS INC (CPIX) Snapshot price: $1.41
Vice President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.00K |
—
|
—
|
0
|
Apr 14
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||